Navigation Links
SpineSmith Partners Announces FDA Clearance and Product Launch of VisuALIF Interbody Fusion Device at North American Spine Society Annual Meeting
Date:10/7/2010

AUSTIN, Texas, Oct. 7 /PRNewswire/ -- SpineSmith Partners, a Texas-based medical device company, today announced the company has received FDA clearance for commercial sale in the United States of its VisuALIF Interbody Fusion Implant System.  The VisuALIF System is being launched this week and is currently on display at the North American Spine Society's annual meeting in Orlando, Florida.

The VisuALIF is a two-piece, stand alone device indicated for intervertebral body fusion of the lumbar spine.  VisuALIF is the first modular lumbar interbody device with an open-face allowing in situ graft placement, tactile feedback with face plate attachment and device placement flush with the anterior aspect of the vertebrae.  The device is available in a range of product sizes and configurations designed to meet surgeon requirements across a wide spectrum of patient anatomy.  

SpineSmith's General Partner, Kevin Dunworth, believes the VisuALIF will offer a unique solution for surgeons.  

"The VisuALIF incorporates an anterior open-face allowing surgeons to visualize disc and end plate preparation leading to optimum graft placement with respect to available volume.  With our launch at NASS, the VisuALIF is 'Now Open for Fusion,'" said Dunworth.

About SpineSmith Partners LP

SpineSmith Partners, LP designs, develops and markets implants and biologics for surgical fixation, correction and tissue regeneration of the spine. SpineSmith takes a different approach from other companies, utilizing a collaborative approach between scientists, engineers and spine surgeons. It's this unique approach that gives spine surgeons the ability to directly impact the direction of their product portfolio, ensuring applicability and achieving the highest standards of patient care.

Founded in Austin, Texas, in 2006, SpineSmith has developed a range of devices with direct surgeon input into the design of spine technology. www.spinesmithusa.com


'/>"/>
SOURCE SpineSmith Partners, LP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
2. SpineSmith Partners and Celling Technologies Hire New VP of Research and Development
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
7. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
8. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
9. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
10. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
11. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... WASHINGTON , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, ... to Washington, D.C. offering free MRI brain scans to the public.Where:  ... – will be parked at 501 K Street NW, Washington, D.C.What:BTF brings ...
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... 2017  For nearly two decades, New Life Agency has been committed ... industry. Today, New Life Agency announces a powerful three-way partnership designed to ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
Breaking Medicine Technology:
(Date:9/21/2017)... ... September 21, 2017 , ... A new addiction ... at a time when Virginia faces an opioid epidemic. , Last ... increase of 38 percent from 2015, underscoring the need for additional addiction treatment ...
(Date:9/21/2017)... Fort Worth, TX (PRWEB) , ... September 21, ... ... top 50 senior housing operators, announces the acquisition of Isle at Kingwood Assisted ... Isle at Kingwood is an established retirement community with 55 assisted living apartments, ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... the Month, Lewis and Clark College Emeritus Professor of Education Gregory A. Smith ... co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and the Failure ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... of Excellence (CoE) with the latest Artificial Intelligence (AI) thinking, announced today the ... quick and easy access to essential information that offers a more comprehensive understanding ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... as one of the Best Places to Work in the Research Triangle for ... Workplace. Once nominated, a company had to meet a threshold in employee participation--a ...
Breaking Medicine News(10 mins):